Blood Advances

Published by: American Society of Hematology  

People

  1. Devlin
    Devlin
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Giralt
    Giralt
  7. Palomba
    Palomba
  8. Shaffer
    Shaffer
  9. Silverberg
    Silverberg
  10. Chinapen
    Chinapen

Groups

  1. Bone Marrow Transplant (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Biostatistics Service (7)
  6. Epidemiology and Biostatistics (7)
  7. CTCR Scholars (6)
  8. Survivorship Research (6)
  9. MSK Grad Students (5)
  10. Master of Science in Clinical and Translational Cancer Research (5)
Search Within
  1. "Jessica Flynn"
Formats
  1. Journal Article (7)
  2. Research Letter (1)
Groups
  1. Bone Marrow Transplant (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Biostatistics Service (7)
  6. Epidemiology and Biostatistics (7)

More Groups

People
  1. Jessica Flynn (8)
  2. Miguel-Angel Perales (7)
  3. Sean Devlin (7)
  4. Gunjan Shah (5)
  5. Michael Scordo (5)
  6. Brian Shaffer (3)

More People

Years
  1. 2023 (5)
  2. 2021 (1)
  3. 2020 (2)
Publishers
  1. American Society of Hematology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma
    Journal Article

    Scordo, M.; Flynn, J. R.; Gonen, M.; Devlin, S. M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
    Journal Article

    Fingrut, W. B.; Gyurkocza, B.; Flynn, J.; Davis, E.; Devlin, S.; Scaradavou, A.; Chinapen, S.; Quach, S.; Cho, C.; Giralt, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients
    Research Letter

    Fingrut, W. B.; Chinapen, S.; Flynn, J.; Katrichis, A.; Stewart, M.; Davis, E.; Shaffer, B. C.; Shah, G. L.; Barker, J. N.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
    Journal Article

    Wudhikarn, K.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Brower, J.; Bachanova, V.; Nastoupil, L. J.; McGuirk, J. P.; Maziarz, R. T.; Oluwole, O. O.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save

    • Blood Advances – authorized name for:

    Name ISSN / ISBN Publisher
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 American Society of Hematology
    Blood Advances 24739529 Unknown
    Blood advances 24739537 American Society of Hematology
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 American Society of Hematology
    Blood Advances 2473-9529 American Society of Hematology
    Blood Advances 2473-9529 American Society of Hematology
    Blood advances 2473-9529 American Society of Hematology
    Blood Advances 24739529 Begell House, Inc
    Blood Advances 2473-9529 Elsevier Inc.